Catalyst Wire Dossier Catalyst Wire Dossier

Lifitegrast ophthalmic solution

lifitegrast
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lifitegrast ophthalmic solution, covering 2025-03-17 to 2025-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease [Phase 3]

See pricing